Norethindrone

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Norethindrone

Property Description
Active ingredient Norethindrone (Norethisterone)
Form Oral tablet
Pharmacological class Progestogen (Synthetic Progestin)
Common use Hormonal regulation and management
Origin Synthetic (19-nortestosterone derivative)

What Type of Medicine is Norethindrone (Norethisterone)?

Norethindrone, known scientifically by the International Nonproprietary Name (INN) Norethisterone, is a prescription-only medication belonging to the progestogen class of synthetic hormones. It functions as a powerful synthetic progestin and is most commonly administered as an oral tablet. The core function of this compound is to provide controlled hormonal regulation. The compound is recognized for its high oral activity and stability. Progestins like Norethindrone are tools for providing reliable hormonal effects in the body, which allows for the establishment of a necessary hormonal balance.

Is Norethindrone a Synthetic or Natural Hormone?

Norethindrone is a synthetic hormone, structurally developed in a laboratory setting. Its unique composition classifies it as a 19-nortestosterone derivative, meaning it has been chemically engineered to enhance its specific pharmacological properties and stability. This specific synthetic modification ensures the drug can provide a predictable, sustained level of the active ingredient in the bloodstream. Due to this synthetic origin, it is defined as a highly effective synthetic sex steroid that provides potent, targeted progestational activity.

What is the General Purpose of Norethindrone?

The general purpose of Norethindrone centers on introducing a specific, controlled progestational effect to the body. It works by binding to progesterone receptors in target tissues, mimicking the natural hormone's signaling. Progestins are therapeutic agents used for managing reproductive function. This function helps to stabilize and regulate the uterine lining (endometrium) and overall hormonal cycles.

What side effects are possible with Norethindrone?

Possible side effects and safety information

The safety profile of Norethindrone (Norethisterone) is documented by regulatory authorities, classifying possible effects by frequency and the body system involved.

Officially Documented Adverse Reactions

The most frequently cited adverse reactions in official labeling are generally hormonal or cosmetic in nature. Adverse effects classified as common (ge 1/100 to < 1/10) include irregular uterine bleeding (such as breakthrough bleeding or spotting), headache, nausea, dizziness, acne, and changes in body weight [DailyMed, Norethindrone tablet].

Adverse reactions are grouped by System-Organ Class, with effects noted in the Reproductive System and Breast Disorders (e.g., amenorrhea, breast pain) and Skin and Subcutaneous Tissue Disorders (e.g., melasma, alopecia) [SmPC, Norethisterone 5mg Tablets]. Norethindrone use is also associated with effects on the Nervous System (headache) and Psychiatric Disorders (mood swings, depression).

Serious Adverse Reactions and Safety Constraints

Regulatory documents highlight that the use of Norethindrone is associated with rare but serious risks, detailed in official warnings. These include a potential increased risk of thromboembolic and thrombotic events (such as Deep Vein Thrombosis or Pulmonary Embolism) and the possibility of developing hepatic neoplasia (liver tumors) [DailyMed, Norethindrone tablet].

Safety restrictions documented in official prescribing information state that Norethindrone is contraindicated in patients with a history of thromboembolic disorders, active liver disease, known or suspected breast carcinoma, or undiagnosed abnormal genital bleeding. The medicine is also contraindicated in known or suspected pregnancy due to potential fetal harm.

Overdose and Emergency Response

The official regulatory profile for Norethindrone indicates that the medication possesses a generally low acute toxicity. Based on authoritative documentation, severe or life-threatening outcomes are not expected to result from an overdosage. Documented clinical manifestations are typically limited to non-specific signs, which include nausea, vomiting, and breast enlargement. Additionally, the regulatory information notes that vaginal bleeding may occur as a delayed symptom following an overdosage.

In the event of a known or suspected overdosage, governmental guidance mandates that individuals must seek immediate medical attention and contact a regional Poison Help line or equivalent emergency service. This action is required for all cases of overdosage.

The management approach is defined as strictly symptomatic and supportive because no specific antidote is known for this compound. While the drug is classified as having very low toxicity, regulatory prescribing information specifies conditional procedural steps: gastric lavage may be considered by medical professionals only if a large overdosage is confirmed and the patient is seen within four hours of ingestion. Hospital monitoring may be required to observe the patient’s status. This ensures that any clinical manifestation, regardless of the severity classification, is addressed through professional, supportive care.

Therapeutic Uses of Norethindrone

What Norethindrone Treats: Main Uses and Benefits

Norethindrone is used to manage various gynecological conditions. This medication is indicated for the management of secondary amenorrhea (the absence of menstruation), endometriosis, and abnormal uterine bleeding due to hormonal factors, provided no organic pathology is present.

In these clinical scenarios, Norethindrone is prescribed to address bothersome and disruptive symptoms. For instance, in cases of abnormal bleeding, it may assist in the modulation of irregular bleeding patterns. The primary therapeutic goal for the patient is the potential reduction of pain, support for changes in bleeding patterns, or assistance with the return of menstrual flow.


Quick Fact: Relief for Abnormal Uterine Bleeding Norethindrone is commonly used to help manage unpredictable bleeding that may arise from hormonal imbalance.

Eligibility and Restrictions for Use

Official Eligibility Rules for Norethindrone

The eligibility for Norethindrone use is strictly defined by regulatory documents based on patient health status, life stage, and pre-existing conditions.

Classification Eligibility Status (as per Official Labeling)
Populations for Whom Use Is Contraindicated Absolute non-eligibility is defined for women with a known or suspected pregnancy, a history of arterial or venous thrombotic disorders (e.g., stroke, blood clots), or active progestin-sensitive cancer (e.g., breast carcinoma) [Source: FDA/DailyMed, SmPC]. Contraindication also applies to undiagnosed abnormal genital bleeding and active liver disease or liver tumors [Source: FDA/DailyMed, SmPC].
Age-Related Eligibility Use is generally restricted to adults and post-menarcheal adolescents. The drug is not recommended for pre-menarcheal children and should not be used in elderly women, as its safety and effectiveness are not established in the geriatric population [Source: FDA/DailyMed].
Conditional Use Populations Patients with pre-existing conditions such as epilepsy, migraine headaches, cardiac dysfunction, or renal dysfunction require careful observation by a healthcare provider due to the potential for fluid retention. Patients with diabetes mellitus or hyperlipidemias require close monitoring [Source: FDA/DailyMed].
Pregnancy and Lactation Status Use during pregnancy is contraindicated. Use during lactation is not recommended [Source: FDA/DailyMed].

Connection to the overall eligibility profile: Regulatory documents define who can and cannot use the medicine by establishing clear absolute prohibitions based on vascular, oncologic, and hepatic risk factors. Eligibility is further structured by age-based restrictions and conditions for conditional use requiring close medical observation.

What should I know about interactions with other medicines?

The official regulatory documents define the interaction profile of Norethindrone based on its susceptibility to metabolic changes and potential additive risks.

Interaction Scope

Classification Interacting Entity/Mechanism
Formally Contraindicated Combination Co-administration with the Hepatitis C drug combination of Ombitasvir/Paritaprevir/Ritonavir, with or without Dasabuvir, is strictly prohibited due to the documented risk of elevated liver enzymes (ALT).
Reduced Systemic Exposure CYP3A4 enzyme inducers (e.g., Rifampin, Phenytoin, Carbamazepine, and the herbal product St. John’s wort) increase the clearance of Norethindrone, leading to a reduction in its systemic exposure.
Increased Systemic Exposure CYP3A4 enzyme inhibitors (e.g., Itraconazole, Ketoconazole, and Grapefruit juice) decrease the clearance of Norethindrone, resulting in an increase in its systemic exposure.

Interaction-Related Constraints

Norethindrone may affect the systemic concentrations of other co-administered medicinal products, leading to documented alterations in the plasma levels of drugs such as Cyclosporine (increased levels) or Lamotrigine (decreased levels). A procedural constraint requires discontinuation at least 4 weeks before major surgery involving prolonged immobilization, due to the documented risk of venous thromboembolism. Additionally, the official labeling notes that the drug may be poorly metabolized in patients with impaired liver function, which directly alters drug clearance.

Connection to the Overall Interaction Profile

The regulatory profile is structured around the required management of systemic exposure levels and the avoidance of hepatotoxic or thrombotic risks when co-administered. The profile highlights explicit restrictions via contraindicated combinations and outlines mandatory timing-based constraints tied to pharmacodynamic risks.

Mechanism of Action

Hormone Receptor Activation and Genetic Signaling

Norethindrone acts as an agonist primarily by binding to and activating the progesterone receptor (PR), initiating a cascade of genetic signaling. This action establishes a hormonal feedback signal that is crucial for subsequent control of the reproductive axis.


Negative Feedback on the HPO Axis

The receptor activation causes negative feedback on the hypothalamic-pituitary-ovarian (HPO) axis, suppressing the release of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). This suppression is the central mechanism that prevents the mid-cycle LH surge, leading directly to the physiological outcome of anovulation.


Peripheral Tissue Modulation

In addition to central control, the drug modifies peripheral reproductive tissues by altering the structure of the endometrium and the cervical mucus. This results in a thickened, viscous cervical mucus that impedes sperm transport, and a uterine lining that is less receptive to implantation, contributing to the overall biological consequence.

Dosage and Administration Information

The administration of Norethindrone (Norethisterone) involves specific administration routes, dosing patterns, and schedules.

Administration Scope

Instruction Detail
Route of administration: Oral intake only, utilizing the tablet form.
Dosing schedule: Dose ranges from a continuous daily low of 0.35 mg to a therapeutic maximum of 15 mg daily for certain conditions. For secondary amenorrhea, a range of 2.5 mg to 10 mg daily is typically used.
Timing in relation to meals (if applicable): May be administered without regard to meals (with or without food).
Preparation requirements (if applicable): The tablet is to be swallowed whole with liquid.
Age-group administration rules: Safety and efficacy have not been established in patients before menarche.
Missed-dose rules: For continuous progestin-only regimens, a critical instruction applies: if a dose is missed by more than 3 hours, specific procedural steps must be followed.

Instruction Classifications (High-Level)

Classification Detail
Administration method type: Oral
Frequency pattern: Daily (once daily or in divided doses).
Use-context constraints: Administration is either in short-term cyclic courses (e.g., 5 to 10 days) or uninterrupted continuous daily courses

Resulting Procedural Structure

Step sequence:

  • The instruction requires a regimen to be established as either cyclic or continuous, based on the specific condition.
  • For continuous use, the tablet must be taken at the same time each day to ensure consistent progestational effect.
  • For dose escalation regimens (e.g., endometriosis), the daily dose is gradually increased according to a defined schedule.

Connection to the overall use protocol: The usage instructions establish whether the medicine is taken in cycles or continuously, defining the necessary dose range and frequency for various uses. These rules set the procedural constraints, such as the required time consistency for continuous use and the handling of missed doses, to maintain the administration protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Norethindrone

Evidence for use in Endometriosis

Norethindrone was studied for use in people with endometriosis, a condition characterized by fluctuating or episodic manifestations of symptoms like pelvic pain. The research, which includes Randomized Controlled Trials (RCTs), has primarily focused on episodes where symptoms become more noticeable. These studies monitored outcomes related to physical discomfort, such as changes in patient pain scores, and outcomes describing episodic or acute changes in bleeding patterns. The research was evaluated primarily in reproductive-age women, with some studies also including adolescents and young adults.

Studies report how symptoms evolved in the observed populations over defined time intervals, often a medium-term duration of 6 to 12 months. Findings describe patterns observed in the studies regarding the stabilization of the uterine lining. Research explored whether the medicine was associated with pain and unscheduled bleeding.

Evidence for use in Abnormal Uterine Bleeding

Studies that examined unscheduled bleeding and the establishment of predictable menstrual patterns include comparative trials and long-standing regulatory reviews. Research monitored outcomes related to systemic or functional imbalance by examining the cessation of bleeding and the volume of blood loss over short periods.

Studies report how symptoms evolved in the observed populations by showing that a short course of treatment often results in the induction of a withdrawal bleed after the treatment is stopped. Findings describe group patterns, consistent with its study as an agent to support cycle establishment.

Research Gaps and Areas of Uncertainty

Comparative evidence is lacking in large-scale trials against many newer or alternative standard treatments available. Long-term effects are not fully established regarding the maintenance of symptom control or the durability of the effect after treatment is stopped. Subgroup findings are uncertain, as the original trial populations were often narrow. Findings describe group patterns, not personal outcomes. Research is ongoing to provide broader context and address these known limitations.

Key Studies & References

  1. Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique®) in the treatment of endometriosis symptoms
  2. Norethisterone - WHO Electronic Essential Medicines List (eEML) (Used for excessive menstruation/irregular cycle)

Frequently Asked Questions (FAQ)

Common questions about Norethindrone (FAQ)


Q: How quickly does Norethindrone start working to stop heavy bleeding?

A: Official product information suggests that when Norethindrone is used to treat heavy uterine bleeding, the bleeding typically stops within one to three days after the treatment is started. This rapid response is part of the expected effect on the uterine lining.


Q: Does taking Norethindrone cause weight gain or changes in appetite?

A: Regulatory documents indicate that changes in body weight, including weight gain, are commonly reported side effects. Changes in appetite have also been listed as a possible effect, though the frequency is not precisely known.


Q: Is it common to have breakthrough bleeding when first starting Norethindrone?

A: Yes, it is common to experience light bleeding or spotting, often called breakthrough bleeding, when you first begin taking Norethindrone. Official labeling notes that irregular menstrual patterns are frequently observed among users of this medication.


Q: What happens if you miss a dose of Norethindrone?

A: For progestin-only regimens, if one active pill is missed, official instructions state to take the missed pill as soon as possible and the next pill at the usual time. If a dose is missed by more than a few hours, the product's instructions may recommend using a back-up, non-hormonal method of contraception for a short time to help maintain its effectiveness.


Q: How does Norethindrone affect fertility after stopping the medication?

A: Studies on this type of progestin-only medication suggest that the return to fertility may happen quickly after stopping the medication. It is recognized that a patient may become pregnant soon after discontinuing use.


Q: Is it typical for breasts to feel tender or sore on Norethindrone?

A: Yes, official adverse reaction reports list breast pain or tenderness and breast enlargement as commonly experienced side effects associated with the use of Norethindrone.


Q: What are common drug interactions that reduce the effectiveness of Norethindrone?

A: Regulatory information indicates that certain drugs or herbal products, particularly those that increase the activity of an enzyme called CYP3A4, can reduce the amount of Norethindrone in the body. This reduction may diminish its therapeutic effectiveness and could lead to increased breakthrough bleeding.


Q: What is the function of the progestin-only formulation of Norethindrone?

A: The progestin-only formulation functions to prevent conception primarily by thickening the cervical mucus, which inhibits sperm from reaching the egg. It also changes the uterine lining (endometrium) and suppresses ovulation in about half of the people who use it.


Q: Why is Norethindrone sometimes called a 'mini-pill'?

A: Norethindrone is sometimes called the 'mini-pill' because it is an oral contraceptive that contains only the progestin hormone. This distinguishes it from the combined birth control pills, which contain both estrogen and progestin.


Q: Is hair loss a reported side effect of Norethindrone?

A: Yes, official regulatory documents list hair loss, or alopecia, as a reported adverse reaction associated with this medication. However, the frequency of this side effect is typically not common.


Q: Does Norethindrone make existing migraines worse?

A: Regulatory documents state that patients with existing migraine headaches require careful observation while taking Norethindrone. They note that the sudden onset of a new migraine or a significant change in existing headaches is a signal that the medication's use should be evaluated by a healthcare professional.


Q: Is it normal to feel tired or fatigued when taking Norethindrone?

A: Tiredness or fatigue is not listed as a common side effect in official documents, but related nervous system effects like somnolence (drowsiness) and unusual tiredness or weakness have been reported as adverse reactions.


Q: Can I take Norethindrone while breastfeeding?

A: Regulatory sources advise caution, as Norethindrone is excreted in breast milk. Some official summaries indicate that the use of this drug while breastfeeding is generally not recommended.


Q: Why does Norethindrone sometimes cause spotting?

A: Spotting, or irregular genital bleeding, is a known side effect of Norethindrone. This occurs because the medication works by changing the uterine lining (endometrium), which is associated with irregular bleeding patterns.


Q: Can this medication be used just to delay a menstrual period?

A: Yes, in certain regulatory jurisdictions, Norethindrone is officially indicated for the postponement of menstruation. This is achieved through a specific regimen leading up to the expected start date of the period.


Q: What should I do if my stomach is upset after taking Norethindrone?

A: If you experience an upset stomach, such as nausea or vomiting, some patient information materials suggest taking the medication with food. Patient information materials may suggest talking to a healthcare professional for guidance on managing this issue.


Q: Is Norethindrone a common treatment for secondary amenorrhea?

A: Yes, official dosing information confirms that Norethindrone is prescribed for the treatment of secondary amenorrhea, which is the absence of menstruation in a patient who has previously had cycles. The drug is officially prescribed for secondary amenorrhea to manage the menstrual cycle, typically utilizing a short-term course.


Q: Does Norethindrone lower libido or cause sexual side effects?

A: Adverse reaction reports list changes in libido (sexual drive) as a potential side effect, though the incidence is not well-established. Changes in sexual ability or performance have also been reported.


Q: What are the signs of a serious side effect from Norethindrone that require medical attention?

A: Official warnings describe signs of serious events, such as a blood clot, that require that you promptly seek medical help. These symptoms include chest pain, difficulty breathing, or sudden swelling in an arm or leg. Signs of liver problems, like yellowing of the skin or eyes, should also be reported right away.


Q: Is it possible to develop an allergy to Norethindrone?

A: Yes, regulatory documents list allergic reactions, including rash, hives (urticaria), and anaphylactic reactions, as possible adverse events. This indicates that developing an allergy to the medication is possible.


Q: Does using Norethindrone affect blood pressure readings?

A: Official regulatory labeling mentions high blood pressure (hypertension) as a condition that must be monitored. If a patient experiences a significant increase in blood pressure while on Norethindrone, the medication may need to be discontinued.


Q: What kind of studies have been done on the long-term safety of Norethindrone?

A: The research summary for Norethindrone notes that while many short- and medium-term studies exist, the long-term effects are not fully established. Specifically, long-term safety regarding the maintenance of symptom control after stopping treatment is an area where further research is needed.


Q: Why is it important to take Norethindrone at the exact same time every day?

A: For the progestin-only formulation, strict adherence to the dosing schedule is critical for consistent effectiveness. The drug’s levels in the bloodstream decrease quickly, meaning its effect is highly dependent on taking the pill at the exact same time every day to maintain a consistent hormonal level.

How should Norethindrone be stored and disposed of?

How to Store and Dispose of Norethindrone

The storage and disposal of Norethindrone oral tablets are governed by official regulatory requirements to maintain product stability and ensure public safety.

Official Storage Requirements

Requirement Condition
Temperature Range Store at Controlled Room Temperature (CRT), 20 C to 25 C (68 F to 77 F).
Environmental Protection Protection from light is required for certain formulations.
Container Rule Store the tablets in the original container or receptacle.
Child Safety Must be strictly kept out of the reach of children.

Storage conditions are essential for preserving the product's integrity until the labeled expiration date.

Official Disposal Instructions

Disposal of unused or expired product must be conducted in accordance with local regulations for pharmaceutical waste. Following these local procedures is required to ensure the correct handling and disposition of the medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Norethindrone found in:

A-Z Index: